Pro Medicus Limited(DE:PMC)
€123.26+-0.36 (+0.20%)
DE:PMC
Pro Medicus Limited financials statements
€123.26
At close:+-0.36 (+0.20%)
Pro Medicus Limited (PMC) Ratios
4 Followers
Pro Medicus Limited Ratios
DE:PMC's free cash flow for Q4 2026 was AU$58.16M. For the 2026 fiscal year, DE:PMC's free cash flow was decreased by AU$-4.11M and operating cash flow was AU$62.27M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.82 | 6.49 | 5.98 | 5.31 | 4.46 |
| Quick Ratio | 6.82 | 6.49 | 5.98 | 5.31 | 4.46 |
| Cash Ratio | 2.80 | 4.05 | 1.74 | 2.96 | 2.37 |
| Solvency Ratio | 1.72 | 1.50 | 1.31 | 1.08 | 0.94 |
| Operating Cash Flow Ratio | 2.44 | 2.58 | 2.51 | 2.10 | 2.32 |
| Short-Term Operating Cash Flow Coverage | 165.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ 196.87M | AU$ 198.35M | AU$ 136.86M | AU$ 100.43M | AU$ 64.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.35 | 1.32 | 1.37 | 1.46 | 1.54 |
| Debt Service Coverage Ratio | 119.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Net Debt to EBITDA | -0.71 | -1.05 | -0.48 | -0.98 | -0.88 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.69% | 99.85% | 75.72% | 73.95% | 99.44% |
| EBIT Margin | 74.94% | 74.03% | 69.87% | 67.06% | 66.69% |
| EBITDA Margin | 78.02% | 77.43% | 74.76% | 73.41% | 74.51% |
| Operating Profit Margin | 74.94% | 74.03% | 69.49% | 67.15% | 66.75% |
| Pretax Profit Margin | 144.26% | 76.71% | 72.17% | 68.96% | 67.49% |
| Net Profit Margin | 101.40% | 54.12% | 51.29% | 48.56% | 47.55% |
| Continuous Operations Profit Margin | 101.40% | 54.12% | 51.29% | 48.56% | 47.55% |
| Net Income Per EBT | 70.29% | 70.55% | 71.07% | 70.42% | 70.45% |
| EBT Per EBIT | 192.50% | 103.62% | 103.85% | 102.69% | 101.11% |
| Return on Assets (ROA) | 43.49% | 34.02% | 32.16% | 30.00% | 28.30% |
| Return on Equity (ROE) | 58.85% | 44.84% | 44.10% | 43.70% | 43.69% |
| Return on Capital Employed (ROCE) | 35.15% | 53.33% | 50.33% | 48.97% | 47.92% |
| Return on Invested Capital (ROIC) | 24.67% | 37.54% | 35.68% | 34.35% | 33.61% |
| Return on Tangible Assets | 45.12% | 36.24% | 34.88% | 33.55% | 32.98% |
| Earnings Yield | 1.25% | 0.39% | 0.58% | 0.88% | 1.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.61 | 3.31 | 3.36 | 3.07 | 3.41 |
| Payables Turnover | 46.20 | 0.22 | 22.54 | 31.50 | 14.11 |
| Inventory Turnover | 0.00 | 3.15 | 799.86 | 591.55 | 301.05 |
| Fixed Asset Turnover | 93.86 | 76.94 | 67.86 | 57.11 | 35.92 |
| Asset Turnover | 0.43 | 0.63 | 0.63 | 0.62 | 0.60 |
| Working Capital Turnover Ratio | 0.97 | 1.04 | 1.06 | 1.11 | 1.15 |
| Cash Conversion Cycle | 132.07 | -1436.11 | 92.92 | 107.86 | 82.51 |
| Days of Sales Outstanding | 139.97 | 110.12 | 108.66 | 118.84 | 107.16 |
| Days of Inventory Outstanding | 0.00 | 115.76 | 0.46 | 0.62 | 1.21 |
| Days of Payables Outstanding | 7.90 | 1661.99 | 16.20 | 11.59 | 25.87 |
| Operating Cycle | 139.97 | 225.88 | 109.11 | 119.45 | 108.38 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.22 | 1.07 | 0.83 | 0.62 | 0.60 |
| Free Cash Flow Per Share | 1.14 | 1.00 | 0.77 | 0.56 | 0.51 |
| Dividend Paid and CapEx Coverage Ratio | 1.74 | 1.97 | 2.01 | 1.99 | 2.24 |
| Capital Expenditure Coverage Ratio | 14.68 | 15.09 | 12.97 | 10.05 | 6.90 |
| Operating Cash Flow Coverage Ratio | 57.14 | 49.37 | 41.94 | 34.99 | 27.30 |
| Operating Cash Flow to Sales Ratio | 0.49 | 0.52 | 0.54 | 0.52 | 0.67 |
| Free Cash Flow Yield | 0.56% | 0.35% | 0.57% | 0.85% | 1.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 80.09 | 259.16 | 171.13 | 113.00 | 99.17 |
| Price-to-Sales (P/S) Ratio | 81.22 | 139.89 | 87.77 | 54.87 | 47.16 |
| Price-to-Book (P/B) Ratio | 47.13 | 115.91 | 75.47 | 49.38 | 43.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 178.91 | 286.51 | 176.92 | 117.50 | 82.84 |
| Price-to-Operating Cash Flow Ratio | 166.72 | 267.52 | 163.28 | 105.80 | 70.83 |
| Price-to-Earnings Growth (PEG) Ratio | 0.61 | 6.60 | 4.73 | 3.24 | 2.29 |
| Enterprise Value Multiple | 103.39 | 179.63 | 116.92 | 73.77 | 62.40 |
| Enterprise Value | 21.11B | 29.61B | 14.11B | 6.76B | 4.35B |
| EV to EBITDA | 103.39 | 179.63 | 116.92 | 73.77 | 62.40 |
| EV to Sales | 80.67 | 139.08 | 87.41 | 54.15 | 46.50 |
| EV to Free Cash Flow | 177.69 | 284.85 | 176.20 | 115.96 | 81.69 |
| EV to Operating Cash Flow | 165.59 | 265.98 | 162.61 | 104.42 | 69.84 |
| Tangible Book Value Per Share | 4.10 | 2.26 | 1.61 | 1.12 | 0.76 |
| Shareholders’ Equity Per Share | 4.32 | 2.46 | 1.80 | 1.33 | 0.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.30 | 0.29 | 0.29 | 0.30 | 0.30 |
| Revenue Per Share | 2.50 | 2.04 | 1.55 | 1.20 | 0.90 |
| Net Income Per Share | 2.54 | 1.10 | 0.79 | 0.58 | 0.43 |
| Tax Burden | 0.70 | 0.71 | 0.71 | 0.70 | 0.70 |
| Interest Burden | 1.92 | 1.04 | 1.03 | 1.03 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.03 | 0.05 | 0.06 | 0.07 |
| SG&A to Revenue | 0.06 | 0.19 | 0.19 | 0.19 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Income Quality | 0.48 | 0.97 | 0.00 | 1.07 | 1.40 |
Currency in AUD
